Predictions
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.42
03.12.21
03.12.21
-
03.12.22
03.12.22
7.50%
11.12.21
11.12.21
Risky Investment
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.62
03.12.21
03.12.21
-
03.12.22
03.12.22
0.84%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.28
02.12.21
02.12.21
-
02.12.22
02.12.22
-0.61%
11.12.21
11.12.21
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.96
01.12.21
01.12.21
€6.00
01.12.22
01.12.22
-2.70%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
Krystal Biotech
Start price
Target price
Perf. (%)
€66.00
01.12.21
01.12.21
€50.00
31.12.23
31.12.23
16.67%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Abivax S.A.
Start price
Target price
Perf. (%)
€25.50
01.12.21
01.12.21
€28.00
01.12.22
01.12.22
-31.92%
20.05.22
20.05.22
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Ardelyx Inc.
Start price
Target price
Perf. (%)
€0.99
30.11.21
30.11.21
€1.00
30.11.22
30.11.22
36.36%
11.12.21
11.12.21
Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
ADL Partner S.A.
Start price
Target price
Perf. (%)
€20.00
30.11.21
30.11.21
-
30.11.22
30.11.22
10.00%
10.12.21
10.12.21
Could be worthwhile Investment >10% per year
Athersys Inc.
Start price
Target price
Perf. (%)
€23.38
30.11.21
30.11.21
€25.00
30.11.22
30.11.22
-71.89%
07.07.22
07.07.22
Could be worthwhile Investment >10% per year
Innovative
Few uniques
Valneva SE
Start price
Target price
Perf. (%)
€29.96
30.11.21
30.11.21
€35.00
30.11.22
30.11.22
-66.46%
12.08.22
12.08.22
Could be very worthwhile Investment >20% year
Krystal Biotech
Start price
Target price
Perf. (%)
€77.00
29.11.21
29.11.21
-
29.11.22
29.11.22
-19.48%
10.12.21
10.12.21
Probably not worthwhile Investment
Wacker Neuson NA
Start price
Target price
Perf. (%)
€25.76
29.11.21
29.11.21
€0.000
29.11.22
29.11.22
-35.05%
30.11.22
30.11.22
Known brand
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Valneva SE
Start price
Target price
Perf. (%)
€28.32
29.11.21
29.11.21
-
29.11.22
29.11.22
-65.32%
21.07.22
21.07.22
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Secunet Security AG
Start price
Target price
Perf. (%)
€405.00
29.11.21
29.11.21
-
29.11.22
29.11.22
-4.81%
12.12.21
12.12.21
Could be worthwhile Investment >10% per year
GFT Technologies AG
Start price
Target price
Perf. (%)
€36.25
28.11.21
28.11.21
€39.00
28.02.22
28.02.22
9.79%
28.02.22
28.02.22
Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.00
28.11.21
28.11.21
-
28.11.22
28.11.22
7.65%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€2.64
28.11.21
28.11.21
-
28.11.22
28.11.22
-77.46%
29.11.22
29.11.22
Risky Investment
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€5.24
27.11.21
27.11.21
€8.00
27.11.22
27.11.22
-47.90%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Onxeo S.A.
Start price
Target price
Perf. (%)
€0.41
27.11.21
27.11.21
€0.60
27.11.22
27.11.22
-56.65%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year